aiwiki.page
English
Health / Nutrition & Public Health / international-health-regulations · Works

International Health Regulations

The International Health Regulations establish binding international rules for detecting, reporting, and responding to health threats that may cross national borders.

26 keywords5 linked from8 not yet writtenWritten by AI
World Health Org…TradePublic HealthCholeraPlague (disease)SmallpoxHIV/AIDSWorld Health Ass…Internatio…

The International Health Regulations (IHR) are a legally binding framework governing how participating states and the World Health Organization (WHO) prepare for and respond to health risks that can spread internationally. Their central purpose is to prevent, protect against, control, and respond to the international spread of disease while avoiding unnecessary interference with international traffic and trade. Although their historical origins lie in epidemic control at ports, the modern Regulations cover a much wider range of public health events, including threats arising from biological, chemical, and radiological hazards.

The principal modern text, adopted in 2005 and effective from 15 June 2007, replaced a system focused on a short list of named diseases with obligations to assess events, communicate risks, maintain public health capacities, and coordinate responses. The Regulations provide the legal basis for declaring a public health emergency of international concern, or PHEIC. Amendments adopted in 2024, which began entering into force for most States Parties in September 2025, added provisions concerning pandemic emergencies, national coordination, equity, health products, and financing.

The IHR combine international obligations with nationally implemented measures. WHO can request information, assess risks, declare emergencies, and issue recommendations, but it does not acquire authority to impose domestic lockdowns, compulsory vaccination, or border closures. The framework therefore depends on the interaction of international coordination, national legal authority, scientific assessment, and sustained investment in public health institutions.

Historical development and legal foundations

The IHR developed from nineteenth-century efforts to reconcile epidemic prevention with maritime commerce. The first International Sanitary Conference met in Paris in 1851, bringing together governments concerned principally with cholera, plague, and yellow fever. Ships, passengers, and cargo could be detained under widely differing national quarantine rules, creating commercial disruption without necessarily providing effective protection. Successive conferences and conventions sought to standardize notification and port measures, although scientific disagreement and competing economic interests repeatedly complicated agreement.

After WHO was established in 1948, this fragmented system was consolidated under its constitutional authority. The International Sanitary Regulations, adopted in 1951, addressed six quarantinable diseases: cholera, plague, yellow fever, smallpox, typhus, and relapsing fever. They were renamed the International Health Regulations in 1969. Later amendments narrowed their disease coverage; after the removal of smallpox in 1981, the principal notification framework concerned cholera, plague, and yellow fever. This disease-list approach became increasingly inadequate as previously unknown infections emerged and international air travel accelerated transmission.

Several developments exposed the limitations of the older system. The appearance of HIV/AIDS, outbreaks of viral haemorrhagic fevers, and the international spread of severe acute respiratory syndrome in 2003 demonstrated that major threats could fall outside the listed diseases. SARS also showed the importance of information originating beyond official government notifications, including clinical networks and reports of unexplained illness. Revision of the Regulations had already been initiated in the 1990s, but the SARS outbreak gave the process additional urgency. The World Health Assembly adopted the revised text through resolution WHA58.3 on 23 May 2005.

The legal form of the IHR is distinctive. They were adopted under Articles 21 and 22 of the WHO Constitution, which allow the Health Assembly to make regulations in specified technical areas. Unlike an ordinary treaty requiring each state to ratify it separately, such regulations enter into force for WHO members following notification, subject to the constitutional procedures for rejection or reservations. Non-member states may also become parties under the Regulations’ provisions.

Their binding character must be distinguished from the legal status of particular WHO actions. States Parties undertake obligations under international law, including duties concerning notification and national capacities. By contrast, temporary and standing recommendations issued under the IHR are expressly non-binding advice. The system thus combines binding procedural and capacity obligations with advisory international guidance, rather than establishing a supranational health authority.

Scope, governing principles, and institutional responsibilities

The modern IHR are organized around events and risks rather than a closed catalogue of pathogens. “Disease” is defined broadly as an illness or medical condition, irrespective of origin or source, that presents or could present significant harm to humans. A public health risk concerns the likelihood of an event adversely affecting human populations, particularly where it may spread internationally or present a serious and direct danger. This construction allows the Regulations to address an unexplained cluster before a pathogen has been identified and to encompass some chemical or radiological incidents as well as infectious diseases.

The breadth of coverage does not mean that every health problem must be reported internationally. A state must assess whether an event meets the relevant notification criteria, including its seriousness, unusual character, and potential international consequences. Routine domestic disease management remains primarily a national responsibility. Conversely, a localized incident can become internationally relevant without already having crossed a border—for example, if a dangerous infection occurs near an international transport hub or creates a substantial risk of exportation.

Article 3 establishes principles governing implementation. These include respect for human dignity, human rights, and fundamental freedoms, together with reference to the United Nations Charter and the WHO Constitution. The Regulations also recognize states’ sovereign authority to legislate and implement health policies, subject to their obligations under the IHR. The 2024 amendments added explicit reference to equity and solidarity. These principles matter because measures that reduce transmission can also restrict movement, affect livelihoods, or expose individuals to coercive procedures.

Each State Party must designate a National IHR Focal Point, a national centre accessible at all times for communications with WHO. Its functions include sending urgent notifications and consolidating information from relevant domestic sectors. It is not necessarily the institution that commands an emergency response: communications authority, operational control, and ministerial decision-making may sit in different bodies. WHO, in turn, maintains IHR Contact Points through which urgent information can be exchanged.

The 2024 amendments also require the designation or establishment of a National IHR Authority to coordinate implementation within a state’s jurisdiction. This addresses a recurring institutional problem: obligations concerning laboratories, ports, transport, customs, health services, and emergency financing cannot be fulfilled by a health ministry acting alone. The authority and focal point may be organized according to national circumstances, but their roles are conceptually distinct. One coordinates implementation across government; the other serves as the continuously available communications channel required by the Regulations.

Event assessment, notification, and information exchange

The notification system is centred on the decision instrument in Annex 2. It asks national authorities to assess four main questions: whether the public health impact is serious; whether the event is unusual or unexpected; whether there is a significant risk of international spread; and whether there is a significant risk of international travel or trade restrictions. For events evaluated through this part of the instrument, affirmative answers to at least two questions normally trigger notification. The assessment concerns the event in context, not simply the name of a disease.

Annex 2 gives special treatment to certain infections. A case of smallpox, poliomyelitis due to wild-type poliovirus, human influenza caused by a new subtype, or SARS must be notified because these events are considered unusual or unexpected and potentially serious. Other specified diseases, including cholera, pneumonic plague, yellow fever, certain viral haemorrhagic fevers, and West Nile fever, must always lead to use of the decision instrument. Events of unknown cause are also assessed, preventing lack of a laboratory diagnosis from becoming a reason to withhold information.

Article 6 requires notification to WHO, through the National IHR Focal Point, within 24 hours of assessment of public health information indicating that an event may constitute a PHEIC. This is not simply a universal “24 hours after the first case” rule. Annex 1 separately establishes expectations for rapid detection and reporting locally and for national assessment of urgent reports within 48 hours. Together, these provisions create a chain from local recognition to national assessment and international notification.

Notification begins an ongoing exchange rather than completing a single reporting form. States must continue communicating timely, accurate, and sufficiently detailed information available to them, including case definitions, laboratory results, sources and types of risk, case and death numbers, conditions affecting spread, and measures taken. Relevant difficulties and support needs must also be reported. The framework permits consultation with WHO when information is insufficient to complete the decision instrument, allowing uncertainty to be discussed before a definitive emergency judgment is possible.

WHO may also consider information from sources other than formal notifications. Under Articles 9 and 10, it can assess such reports and request verification from the state concerned. The state must acknowledge or initially reply to a verification request within 24 hours and provide available public health information within a further specified 24-hour period. These provisions reduce exclusive dependence on voluntary official announcements while preserving procedures for consultation. Information sharing is also constrained by confidentiality rules and the personal-data protections of Article 45, linking international early warning to data privacy obligations.

Core capacities and the domestic public health system

The IHR require states to develop and maintain capacities to detect, assess, notify, and report events and to respond promptly and effectively to public health risks and emergencies. Annex 1 describes these functions at local, intermediate, and national levels, as well as at designated points of entry. The original 2005 timetable generally allowed five years after entry into force to establish the required capacities, with procedures for extensions. The obligations concern functioning institutions and services, not merely the adoption of a preparedness plan.

At community and local levels, the essential task is recognizing unusual illness or death and reporting relevant information rapidly. This depends on accessible clinical services, trained personnel, reliable communication, and workable reporting thresholds. At intermediate levels, authorities must confirm reported events, support control measures, and transmit urgent information nationally. At national level, the system must be able to assess reports, connect technical specialists, coordinate response, and communicate with WHO. The chain fails if any level cannot recognize a signal or pass it to an institution able to act.

Public health surveillance is therefore broader than counting laboratory-confirmed cases. Indicator-based systems track defined conditions through routine reporting, while event-based approaches detect unusual clusters, community reports, or other signals requiring investigation. Laboratory networks establish the identity and characteristics of hazards, and epidemiological investigation determines their distribution, likely transmission pathways, and populations at risk. An effective system links these components so that a laboratory finding leads to assessment and action rather than remaining an isolated technical result.

Response capacity involves personnel, logistics, coordination, and continuity of services. Outbreak investigation teams may require transport, protective equipment, specimen referral arrangements, infection prevention expertise, and access to treatment facilities. Risk communication must explain what is known, what remains uncertain, and why measures are being introduced. Chemical and radiological incidents may require agencies outside the health sector. These operational requirements connect the IHR with the wider health system, including emergency care, procurement, workforce planning, and dependable public administration.

Implementation is assessed through several complementary instruments. States report capacities through the annual self-assessment process commonly known as SPAR, while the Joint External Evaluation provides a voluntary external assessment. Simulation exercises test plans under constructed scenarios, and after-action reviews examine actual events. These instruments belong to the broader monitoring and evaluation framework; they are not all separate compulsory treaty procedures. Their results also require careful interpretation: a country may have laboratories and written plans yet face failures in decision-making, public trust, surge staffing, or equitable service delivery during a major emergency.

Emergency determinations and WHO recommendations

A PHEIC is an extraordinary event determined to constitute a public health risk to other states through international disease spread and potentially to require a coordinated international response. The declaration is a legal and coordination mechanism, not a synonym for a large epidemic or a scientific classification of transmissibility. A relatively small event can qualify if its characteristics and international implications are sufficiently serious, while the existence of widespread disease does not automatically determine the legal conclusion.

The WHO Director-General makes the determination under Article 12. Relevant considerations include information supplied by the affected state, the Annex 2 decision instrument, scientific principles and evidence, and assessments of risks to human health, international spread, and international traffic. The Director-General also receives advice from an IHR Emergency Committee assembled from relevant experts. The affected state is consulted and may present its views. The committee advises on whether an emergency exists, whether it should end, and what temporary recommendations are appropriate; the legal determination remains with the Director-General.

Temporary recommendations may concern surveillance, clinical information, vaccination, screening, contact tracing, quarantine, isolation, and international travel measures. Their content should reflect the particular event, rather than follow automatically from the declaration. Recommendations generally expire three months after issuance unless modified or extended through the prescribed process. Standing recommendations are a separate instrument intended for routine or periodic application to specific ongoing public health risks. Neither type is legally binding in itself, although States Parties have binding duties under other provisions of the Regulations.

The first PHEIC was declared in April 2009 for the emergence of influenza A(H1N1). Subsequent declarations included the international spread of poliovirus in 2014, the West African Ebola outbreak in 2014, the Zika-associated cluster of neurological disorders and neonatal malformations in 2016, and the Ebola outbreak in the Democratic Republic of the Congo in 2019. COVID-19 was declared a PHEIC on 30 January 2020; WHO characterized it as a pandemic on 11 March 2020. Those were different acts with different purposes. The COVID-19 PHEIC ended on 5 May 2023, without implying that the disease or its health consequences had disappeared.

The 2024 amendments introduced “pandemic emergency” as a determination within the PHEIC framework for communicable-disease events meeting additional criteria. These concern wide geographical spread, actual or threatened capacity pressures on health systems, substantial social or economic disruption, and the need for rapid, equitable, enhanced international action involving whole-of-government and whole-of-society approaches. This category provides an additional legal signal for the most consequential infectious threats. It does not replace the broader PHEIC mechanism, which remains applicable to other qualifying events.

International travel, points of entry, and health documentation

International transport is a central concern of the IHR because it can both disseminate hazards and sustain the supplies, personnel, and commerce needed for response. The Regulations apply to relevant aspects of travellers, conveyances, baggage, cargo, containers, goods, and postal parcels. They seek to make health measures sufficiently effective without making international movement subject to arbitrary or unnecessarily restrictive requirements. A disease-control intervention must therefore be considered in relation to its public health purpose, available evidence, practical effectiveness, and burdens.

States must designate airports and ports that develop the capacities specified in Annex 1 and may designate certain ground crossings. Routine capacities include access to medical services for prompt assessment and care of ill travellers, arrangements for transporting them safely, trained personnel for inspecting conveyances, and a safe environment for travellers using facilities. Relevant environmental functions include drinking water, food safety, waste disposal, and vector control. During an emergency, designated points of entry also need arrangements for assessment, separation of affected persons, and implementation of recommended measures.

The Regulations distinguish quarantine from isolation. Quarantine restricts activities or separates persons who are not ill but may have been exposed, while isolation separates ill or contaminated persons or affected items to prevent spread. These distinctions matter when judging necessity and proportionality. Subject to specified exceptions and safeguards, the framework gives preference to measures that are less invasive or intrusive. A routine non-invasive examination is legally and operationally different from detention or an invasive procedure, even when all are described loosely as “screening.”

Health documentation includes the International Certificate of Vaccination or Prophylaxis and maritime documents such as Ship Sanitation Control Certificates and Ship Sanitation Control Exemption Certificates. Yellow fever is particularly important because Annex 7 establishes specific vaccination-related entry provisions. An amendment effective in July 2016 made a valid yellow fever vaccination certificate valid for the lifetime of the vaccinated person, replacing the former ten-year validity period. That rule concerns the certificate’s validity under the IHR and is distinct from the broader clinical assessment of an individual’s circumstances.

Article 43 permits states to introduce additional health measures in specified circumstances, but it does not provide unlimited discretion. Measures must be grounded in scientific principles, available scientific evidence, and relevant WHO guidance, and must not be more restrictive of international traffic or more invasive or intrusive to persons than reasonably available alternatives achieving the appropriate level of protection. Measures significantly interfering with international traffic generally trigger requirements to inform WHO and provide a public health rationale and relevant scientific information. The framework thus creates a process for explaining and reviewing national departures from coordinated advice.

Rights, information protection, and equitable access

Public health measures under the IHR affect people directly, making legal safeguards part of the operational framework rather than an external consideration. Article 32 requires states to treat travellers with respect for dignity, human rights, and fundamental freedoms and to minimize discomfort or distress associated with health measures. Relevant considerations include gender, sociocultural, ethnic, and religious concerns. States must also provide or arrange appropriate food, water, accommodation, medical treatment, and means of communication for travellers subject to quarantine, isolation, examinations, or other procedures for public health purposes.

The Regulations address informed consent for medical examinations, vaccination, prophylaxis, and related measures, while recognizing specified exceptions under applicable law and public health circumstances. A person’s refusal does not create an unrestricted international power to compel treatment. The text sets conditions for refusal of entry and, where there is evidence of an imminent public health risk, for measures taken under national law to control that risk. Legal authority, necessity, and procedural protections remain relevant to the particular intervention.

Article 45 governs personal data collected or received under the Regulations. The general rule is confidentiality and anonymous processing as required by national law. Identifiable information may be processed and disclosed where essential to assess and manage a public health risk, subject to safeguards. Data should be handled fairly and lawfully, remain relevant and not excessive for the purpose, be accurate where necessary, and not be retained longer than required. These provisions are particularly important where contact tracing and cross-border investigation involve identifiable travel histories or exposure records.

Distributional issues arise because the ability to comply with an international obligation is uneven. A state may recognize an event but lack diagnostic reagents, emergency staff, or resources for a sustained response. Travellers may experience restrictions differently depending on income, nationality, disability, or access to documentation. Measures that appear technically uniform can therefore have unequal effects. The 2024 amendments’ explicit inclusion of equity and solidarity connects these concerns with implementation, particularly access to relevant health products and assistance for capacity development.

The amended framework strengthens WHO’s role in facilitating access to relevant health products during qualifying emergencies, including assessment of needs and support for equitable access. These provisions operate alongside states’ commitments to collaborate, subject to applicable law and available resources. They do not establish an automatic worldwide allocation entitlement or independently suspend intellectual property rules. Their practical significance depends on manufacturing capacity, procurement arrangements, regulatory systems, financing, and the willingness of states and other actors to cooperate when global demand exceeds supply.

Implementation experience and limits of compliance

The IHR rely heavily on timely disclosure, yet reporting can impose immediate economic costs on the state that first identifies an event. Travel cancellations, import restrictions, and public anxiety may follow even when the state has complied fully with its notification obligations. This creates a structural tension: the international system benefits from early warning, while the reporting country may bear disproportionate short-term losses. Provisions intended to prevent unnecessary interference with traffic and trade are therefore integral to the notification system, not merely commercial exceptions to it.

Experience with the 2014–2016 West African Ebola epidemic highlighted the importance of basic health services and rapid international support. Weak surveillance, limited laboratory access, shortages of trained personnel, and difficulty organizing treatment and safe care impeded control. The PHEIC was declared on 8 August 2014, after transmission had already become extensive. Subsequent reviews examined both national capacities and WHO’s emergency response arrangements. The episode showed that formal obligations to report and respond could not substitute for functioning institutions in affected areas.

The COVID-19 pandemic exposed a different combination of problems. Countries with substantial assessed capacities still encountered shortages of protective equipment, fragmented decision-making, overwhelmed hospitals, and difficulties translating warnings into timely action. National governments introduced border restrictions and other measures that varied widely and did not always follow WHO recommendations. At the same time, international competition for diagnostics, vaccines, and other products revealed limits in the arrangements for equitable access. These experiences broadened attention from identifying outbreaks to the political, logistical, and industrial conditions necessary for response.

Enforcement is comparatively limited. WHO has no general power under the IHR to fine governments, compel entry by inspectors, or override national legislation. It can seek verification, communicate information under the applicable rules, request reconsideration of additional measures, provide technical assistance, and use public reporting and diplomatic engagement. Article 56 provides procedures for dispute settlement, beginning with negotiation or other peaceful means chosen by the parties; arbitration depends on the relevant acceptance arrangements. These mechanisms are not equivalent to an international court exercising automatic jurisdiction over all implementation failures.

Compliance also cannot be reduced to whether a government made a particular announcement on time. Relevant questions include the quality of underlying surveillance, the completeness of information, sustained capacity investment, proportionality of measures, protection of individuals, and cooperation with other states. Monitoring tools can document some of these dimensions, but numerical preparedness scores do not fully capture political decision-making or community trust. A country’s performance may also vary between hazards, regions, and stages of the same emergency, making simple rankings an incomplete representation of its ability to fulfil the Regulations.

The 2022 and 2024 amendments and the evolving legal framework

The amendment process illustrates how the IHR can be revised without replacing their entire legal foundation. In May 2022, the World Health Assembly adopted procedural changes that shortened, for states bound by them, the period before future amendments enter into force from 24 months to 12 months and the period for notifying rejection or reservations from 18 months to 10 months. Those changes became effective in May 2024 for the states to which they applied. Their purpose was to allow later revisions to become operational more quickly while preserving formal opportunities for states to object.

On 1 June 2024, the Health Assembly adopted a broader package through resolution WHA77.17. Its principal elements included the pandemic emergency category, National IHR Authorities, stronger language concerning equity and solidarity, provisions concerning access to relevant health products, and a Coordinating Financial Mechanism. The package also provided for a States Parties Committee for the Implementation of the International Health Regulations. The committee was designed to facilitate implementation through a consultative, non-adversarial, assistance-oriented approach rather than punitive adjudication.

The financial provisions address a longstanding gap between legal duties and the resources available to perform them. The Coordinating Financial Mechanism is intended to promote and support sustainable financing for implementation, including identification of financing needs and relevant sources, and to improve coordination. It is not equivalent to an automatically funded global treasury. Its effectiveness depends on the resources mobilized, the ability of states to access support, and whether financing aligns with national priorities and the capacities required under Annex 1.

The 2024 amendments began entering into force on 19 September 2025 for most States Parties. Application is not legally identical for every state: rejection, reservations, and the applicability of the 2022 procedural amendments can affect the operative text and timetable. Accordingly, analysis of a particular state’s obligations must distinguish the original 2005 framework from the amendments legally applicable to that state. Adoption by the Health Assembly, international entry into force, and any necessary changes to domestic administrative or legal arrangements are related but separate steps.

The IHR also interact with other international instruments without absorbing their functions. The Pandemic Influenza Preparedness Framework, adopted in 2011, addresses sharing of influenza viruses with human pandemic potential and access to associated benefits through a distinct mechanism. The WHO Pandemic Agreement, adopted by the Health Assembly in May 2025, likewise has a separate legal basis and entry-into-force process; its adoption did not itself amend the IHR. The Regulations remain the general cross-border notification and emergency-coordination framework, while such instruments address additional aspects of preparedness, cooperation, and access.

Implementation of the amended Regulations requires practical institutional decisions: which national body coordinates compliance, how urgent information reaches the focal point, how health-product needs are assessed, and how financing supports capacities outside major cities. The legal text establishes responsibilities and channels for cooperation, but their operation depends on national budget cycles, workforce development, laboratory networks, transport systems, and communication arrangements maintained between emergencies.